Vaccine-induced CD8+ T cells control AIDS virus replication

Nature

Volumn 491, Issue 7422, 2012, Pages 129-133

  Mudd, Philip A ^a,b   Martins, Mauricio A ^c   Ericsen, Adam J ^a   Tully, Damien C ^d   Power, Karen A ^d   Bean, Alex T ^a   Piaskowski, Shari M ^a   Duan, Lijie ^e   Seese, Aaron ^d   Gladden, Adrianne D ^d   Weisgrau, Kim L ^a   Furlott, Jessica R ^a   Kim, Young Il ^f   De Santana, Marlon G Veloso ^g   Rakasz, Eva ^h   Iii, Saverio Capuano ^h   Wilson, Nancy A ^a,h   Bonaldo, Myrna C ^g   Galler, Ricardo ⁱ   Allison, David B ^j   Piatak Jr , Michael ^k   Haase, Ashley T ^e   Lifson, Jeffrey D ^k   Allen, Todd M ^d   Watkins, David I ^c   more..

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f University of Alabama at Birmingham   (United States)

^g INSTITUTO OSWALDO CRUZ   (Brazil)

^h UNIVERSITY OF WISCONSIN   (United States)

ⁱ Instituto de Technologia em Imunobiologicos   (Brazil)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k SAIC FREDERICK INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA B27 ANTIGEN; NEF PROTEIN; VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; CONCENTRATION (COMPOSITION); HUMAN IMMUNODEFICIENCY VIRUS; PRIMATE; VACCINATION; VACCINE; VIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CD8+ T LYMPHOCYTE; COLON; CONTROLLED STUDY; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HIV-1; HLA-B27 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; MACACA MULATTA; MALE; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

AIDS VIRUS; ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84868348755     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11443     Document Type: Article

References (24)

1. Deeks, S. G. & Walker, B. D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27, 406-416 (2007).
2. Goulder, P. J. & Watkins, D. I. HIV and SIV CTL escape: implications for vaccine design. Nature Rev. Immunol. 4, 630-640 (2004).
3. Migueles, S. A.&Connors, M. Long-termnonprogressive disease among untreated HIV-infected individuals: clinicalimplications of understanding immune control of HIV. J. Am. Med. Assoc. 304, 194-201 (2010).
4. Fellay, J. et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944-947 (2007).
5. The International HIV Controllers Study. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551-1557 (2010).
6. Loffredo, J. T. et al. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J. Immunol. 182, 7763-7775 (2009).
7. Johnston, M. I. & Fauci, A. S. An HIV vaccine-challenges and prospects. N. Engl. J. Med. 359, 888-890 (2008).
8. Mudd, P. A.&Watkins, D. I. Understanding animalmodels of elite control: windows on effective immune responses against immunodeficiency viruses. Curr. Opin. HIV AIDS 6, 197-201 (2011).
9. Loffredo, J. T. et al. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81, 8827-8832 (2007).
10. Valentine, L. E. et al. Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques. J. Virol. 83, 11514-11527 (2009).
11. Dang, Q. & Hirsch, V. M. Rapid disease progression to AIDS due to Simian immunodeficiency virus infection of macaques: host and viral factors. Adv. Pharmacol. 56, 369-398 (2008).
12. Loffredo, J. T. et al. Patterns of CD81 immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J. Virol. 82, 1723-1738 (2008).
13. Mudd, P. A. et al. Escape from CD81 T cell responses in Mamu-B*008011 macaques differentiates progressors from elite controllers. J. Immunol. 188, 3364-3370 (2012).
14. Li, Q. et al. Peak SIV replication in restingmemoryCD41 T cells depletes gut lamina propria CD41 T cells. Nature 434, 1148-1152 (2005).
15. Li, Q. et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458, 1034-1038 (2009).
16. Hansen, S. G. et al. Effectormemory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nature Med. 15, 293-299 (2009).
17. Hansen, S. G. et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523-527 (2011).
18. Kawada, M. et al. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J. Virol. 82, 10199-10206 (2008).
19. Tsukamoto, T. et al. Impact of cytotoxic-T-lymphocyte memory induction without virus-specific CD41 T-cell help on control of a simian immunodeficiency virus challenge in rhesus macaques. J. Virol. 83, 9339-9346 (2009).
20. Cline, A. N., Bess, J. W., Piatak, M. J. & Lifson, J. D. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J. Med. Primatol. 34, 303-312 (2005).
21. Henn, M. R. et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 8, e1002529 (2012).
22. Macalalad, A. R. et al. Highly sensitive and specific detection of rare variants in mixed viral populations frommassively parallel sequence data. PLOSComput. Biol. 8, e1002417 (2012).
23. Bonaldo, M. C. et al. Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD81 T-cell responses in rhesus macaques. J. Virol. 84, 3699-3706 (2010).
24. Bonaldo, M. C. et al. Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol. J. 4, 115 (2007).